AA
MDGL icon

ALPS Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

ALPS Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,338
Closed -$1.62M – 939
2021
Q3 		$1.62M Sell
20,338
-1,406
-6% -$121K 0.02% 340
2021
Q2 		$2.12M Sell
21,744
-6,235
-22% -$738K 0.02% 319
2021
Q1 		$3.27M Buy
27,979
+75
+0.3% +$8.74K 0.03% 207
2020
Q4 		$3.1M Buy
27,904
+8,222
+42% +$1M 0.03% 210
2020
Q3 		$2.34M Sell
19,682
-1,365
-6% -$148K 0.03% 215
2020
Q2 		$2.38M Sell
21,047
-7,006
-25% -$689K 0.03% 221
2020
Q1 		$1.87M Sell
28,053
-2,967
-10% -$247K 0.03% 219
2019
Q4 		$2.83M Buy
31,020
+263
+0.9% +$25.5K 0.02% 199
2019
Q3 		$2.65M Sell
30,757
-1,516
-5% -$142K 0.02% 192
2019
Q2 		$3.38M Sell
32,273
-4,907
-13% -$526K 0.03% 178
2019
Q1 		$4.66M Buy
37,180
+1,608
+5% +$200K 0.03% 173
2018
Q4 		$4.01M Buy
35,572
+8,378
+31% +$1.3M 0.03% 171
2018
Q3 		$5.82M Buy
27,194
+6,615
+32% +$1.66M 0.04% 152
2018
Q2 		$5.76M Buy
20,579
+1,800
+10% +$316K 0.04% 161
2018
Q1 		$2.19M Buy
18,779
+4,932
+36% +$609K 0.02% 206
2017
Q4 		$1.27M Buy
+13,847
New +$791K 0.01% 224

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ALPS Advisors's MDGL Position: Q4 2021 in Review

ALPS Advisors sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2021, closing a stake of 20,338 shares — an estimated $1.62M sold.

ALPS Advisors first reported a position in MDGL in Q4 2017 and held it in 16 quarters. The position peaked at $5.82M in Q3 2018. 144 funds tracked by Wall St. Rank hold MDGL as of Q4 2021.

  • ALPS Advisors reported no remaining Madrigal Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 20,338 Madrigal Pharmaceuticals shares in Q4 2021, an estimated $1.62M.
  • ALPS Advisors first reported a position in Madrigal Pharmaceuticals in Q4 2017 and held it in 16 quarters.
  • ALPS Advisors's Madrigal Pharmaceuticals position peaked at $5.82M in Q3 2018.
  • 144 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.